As part of the RAS, ACE converts angiotensin I to the potent vasoconstrictor angiotensin II, which can lead to increased oxidative stress and inflammation, exacerbating insulin resistance and beta cell dysfunction [56,57]. Here, ACE is linked to Insulin resistance.